Skip to main content

Mortality in a Moroccan psychiatric hospital

Abstract

Background and objectives

Even though the statistics have shown that patients with severe mental disorders such as schizophrenia and bipolar disorder are most likely to die 10 to 20 years earlier than the general population, the information on mortality in the Moroccan psychiatric setting is significantly limited. In the course of this study, we aim to describe the clinical characteristics and death-related data of the 18 patients who died over 10 years.

Methods

It is a retrospective and descriptive study of deceased inpatients within the Department of Psychiatry of the University Hospital Center, Ibn Rochd. The study extended over a period of 10 years, from January 1, 2011, to January 1, 2021.

Results

The study identified the death cases of 18 patients over 10 years, with a mortality rate of 1.99/1000, in which the average age of death is around 46,4 years. Men represented 55.6% of the deceased patients. 44.4% were diagnosed with schizophrenia, and 39% had medical comorbidity. The most common causes of death were cardiac causes (22.2%), followed by neuroleptic malignant syndrome (16.7%). Suicide, sudden death, and digestive diseases accounted for 11.1% of all causes.

Conclusion

People with mental disorders experience a high mortality rate. In this study, cardiovascular diseases and the neuroleptic malignant syndrome were the main causes of death, which requires close monitoring of high-risk psychiatric patients with comorbid cardiac problems.

Introduction

Researchers have consistently reported that people with mental disorders have a higher mortality risk compared to the general population. In the case of severe mental disorders (schizophrenia and other psychotic disorders, bipolar disorders, and moderate to severe depression), studies have shown premature mortality of 10 to 20 years [1, 2]. Life expectancy for those with severe mental illness is around 15 years lower for women and 20 years lower for men compared to the general population [3].

The excessive rate of mortality cannot only be related to the increased risk of death due to suicide or other injuries; communicable and non-communicable diseases (NCDs) account for most premature mortality [4].

Non-communicable diseases are one of the most important public health challenges worldwide. As in 2016, an estimated 41 million death cases worldwide were caused by non-communicable diseases, most of which (23 million deaths) were specifically attributed to 3 prevalent conditions: cardiovascular diseases, chronic respiratory diseases, and diabetes [5]. However, in NCDs, cardiovascular diseases are the leading preventable cause of early death among people with severe mental illness [6]. A recent systemic review revealed that the mortality rate caused by cardiovascular diseases in Morocco has reached 38%, with ischemic heart disease and stroke being the main events causing death (31.0% and 22.5%, respectively) [7]. Researchers have recognized the importance of increasing the effectiveness of healthcare interventions to decrease the overall mortality rate among this susceptible population [8, 9].

People suffering from mental disorders are more likely to adapt an adversative health behavior, such as tobacco smoking, substance use, physical inactivity, and poor diet. Which in return leads to the higher rates of chronic medical conditions among this category of patients [10, 11].

Our knowledge of the mortality of people with mental disorders in low- and middle-income countries is limited. The data above is drawn from studies from high-income countries, where there is greater awareness and regular screening of people with mental disorders. It would also be necessary to consider Morocco’s reality with its cultural aspects but also to deal with the lack of human and material resources from which our health care system suffers.

The objective of this work is to describe the overall mortality, along with the characteristics related to the deceased patients in the psychiatry department of Ibn Rochd University Hospital in Casablanca over a period of 10 years. These characteristics could be as following identified: socio-demographic characteristics (age, sex, marital status, and the educational background), clinical characteristics (medical, surgical, substance use disorder, and judicial history), family history of mental disorders and/or suicide, psychiatric diagnoses, prescribed treatments such as pharmacological and somatic treatment (electroconvulsive therapy), causes of death, and time between admission and death.

Methods

This is a 10-year retrospective study with a descriptive aim, conducted in the Psychiatric Department of Casablanca University Hospital, Morocco. The department have a capacity of 104 beds. It is responsible for the treatment of patients in the Casablanca-settat region with an estimated population of 6.812 million citizens in 2014. Because of the shortage of psychiatric units in Morocco, the Ibn-Rochd University psychiatric center handle mostly extreme cases. More than 900 patients are admitted annually, and 30 to 40 patients are received every day at the emergency. The majority of patients who are admitted, suffer from schizophrenia, bipolar disorder, or depression.

The study includes data regarding patients being admitted from January 1, 2011, to January 1, 2021. This data was gathered from the files, the hospitalization registers of the departments, the death certificates, and the autopsy reports. Data collection was carried out using a data processing form, based on information in the clinical records.

We included in our study all patients who died during their hospitalization in the Psychiatry Department of the Ibn Rochd University Hospital of Casablanca, whose files were available and complete.

We recorded information regarding the following types charactetistics: socio-demographic, clinical (medical, surgical, toxic, and judicial history), family history of mental disorders and suicide, psychiatric diagnoses, prescribed treatments: pharmacological and somatic treatment (electroconvulsive therapy), causes of death, and time between admission and death.

The data entry and statistical analysis were performed using Google sheet software. The different parameters were calculated and subjected to univariate analysis. The qualitative variables are expressed as percentages. As for the results of the quantitative variables, these are expressed as mean with standard deviation.

The right to direct access to data from the medical records of patients who were hospitalized between January 2011 and January 2021 was granted to us after a request to the head of the Psychiatry Department at the University Hospital of Casablanca, respecting the rules of professional secrecy and anonymity.

Results

9038 patients were admitted from January 1, 2011, to January 1, 2021, into different psychiatric units of the Casablanca Psychiatric Hospital University, in which 18 patients died. The average number of deaths was 1.8 deaths per year with extremes ranging from 1 to 3 deaths per year. The death rate lies by 1.99/1000 admission, while 55.6% of the deceased patients were men. The mean age was 46.4 ± 13.5 sd (standard deviation) with extremes of 24 years and 80 years. 61.1% were aged between 41 and 60ans. 44.4% were married, and 77.8% were unemployed. Among the studied group, the level of education of only 14 patients was known, of which 27% have a high level of education (Table 1).

Table 1 Sociodemographic characteristics

Fourteen patients had an associated physical illness, 3 patients had diabetes, and 2 patients had hypertension. Also, 15 patients had their surgical history noted. Substance use disorder was noted for 12 patients. The prevalence of drug use was 44.4%. Among them, 75% were polysubstance users. 38.8% of the patients were chronic smokers, 27.8% were alcohol users, and 27.8% were cannabis users. As for previous suicidal behavior, 33.3% of the patients had previous suicidal behavior, of which 83.4% of them had suicide attempts and the remaining 16.6% had only suicidal ideation, along with the family history of mental disorders, which 42.9% of the patients had (Table 2).

Table 2 Clinical characteristics

Most of the patients had three or more hospitalizations in a psychiatric ward (38.9%), and only 27.8% were hospitalized for the first time. Regarding the modality of hospitalization, 61.1% of the deceased patients were admitted at the request of a relative and 27.8% of hospitalizations were by police requisition. 44.4% of patients had schizophrenia, 33.3% had bipolar disorder, and 11% had drug induce psychosis. 94.4% of these patients were on antipsychotics. 38.9% of deaths happened in the first week of hospitalization. The causes of death recorded were diverse: 22.2% (4 patients) died because of circulatory disease and 16.7% (3 patients) died because of a neuroleptic malignant syndrome (Table 3).

Table 3 Mortality characteristics in our example

Discussion

This population-based study provides detailed estimates of mortality associated with mental disorders, and the overall mortality in this study was 1.99 deaths per 1000 admissions. The overall mortality is variable in literature, the highest mortality rate is observed in a study by Khamker et al. who observed a mortality rate of 14.7/1000 patients [12], and infectious causes (30.2%) could explain part of the difference in mortality rate compared to our study. The lowest mortality rate was observed in a study conducted in Tunisia in which the rate was similar to ours (2/1000 admissions) [13].

In our departement, and like most Moroccan psychiatric hospitals, we are very strict with the admission of patients with organic causes of mental disease, and that is because of the lack of resources of which our health system suffers, and this could explains in part the low mortality rate in our study.

In this study, there was a slight male predominance (52.9%), which is in line with other studies [12, 14, 15]. Also, 61.1% of the patients had no medical history, and comparable results were found in Ali and colleague’s study where 56.5% of patients had no medical history [16]. Indeed, patients with psychotic disorders often have a limited ability to recognize and communicate the symptoms they suffer from, contributing to a lower detection of illness, along with other factors such as exclusion from screening programs and self-neglect [17]. Meanwhile, in Tunisia, in a study by Zgueb et al., 54% of the patients had a medical history; among them, 80% had cardiovascular risk diseases (hypertension, diabetes, dyslipidemia, coronary artery disease, chronic obstructive pulmonary disease) [13].

According to another study by Fulga et al., 17.2% of the patients had hypertension, 15% had heart failure, 8.6% had diabetes, and 4.3% had chronic obstructive pulmonary disease (COPD) [18]. Our base had 3 patients with diabetes and 2 patients with hypertension which are both major cardiovascular factors [19]. Also, inpatients with mental illnesses have been found to have a higher prevalence of diabetes and abnormal glucose metabolism in comparison to the general population. This outcome may be influenced by the utilization of antipsychotic medication [20].

This high prevalence of substance use among deceased patients may be related to the high substance use among patients with mental health issues. Indeed, a study done in the psychiatry department of the Ibn Rochd Hospital showed similar results with a smoking rate of 68%, which reaches 83% in men hospitalized in the mental health care department [21]. People with severe mental illness have higher cardiovascular disease risk factors, such as high smoking rate, sedentary lifestyle, and obesity, as well as metabolic side effects of antipsychotic treatment [4, 22]. Many researchers have observed that people with severe mental illness might have difficulty in reducing or removing modifiable risk factors because of a lack of motivation, poor communication skills, and poor medication compliance, making it challenging to achieve better outcomes [4, 22].

In our study, 44.4% of the deceased patients had a schizophrenic disorder and 33.3% had a bipolar disorder. Similar diagnostic categories have been found in other studies done in Egypt, Nigeria, and India [14, 16, 23]. This result may be due to the profile of the patients hospitalized in the department. Indeed, a study done in the same department to determine the profile of the patients hospitalized showed that 55.4% of the patients had a schizophrenic disorder and 25.2% had bipolar disorder [21]. We also note that alcohol and drug-related disorders are not managed in our department which explains the absence of those diagnoses in our study.

The high mortality in the first week, as shown in our study, join the result of a study conducted by Osman et al. and another conducted by Shinde et al. which showed respectively that 66.7% and 59.7% of patients die in the first week. This period is crucial because patients are often in the acute phase of their diseases or have new drugs introduced [14, 24].

Natural causes were the leading cause of death in our study, with 22.2% (4 patients) dying due to circulatory disease. This is supported by a meta-analysis of cohort studies conducted on causes of death in patients with mental disorders [25]. Nevertheless, historical data have always been focusing on an overestimation of the rate of non-natural deaths in psychiatric inpatients (suicides, accidents, and homicides). The difference in mortality cannot be attributed to this factor alone [26].

The most frequent causes of death are different according to the studies. Cardiovascular disease, suicide, and sudden death are frequent causes in several studies [13, 15]. Although cardiovascular disease is the most common cause of death in patients with mental disorders [26], they are less likely to receive specialized interventions [27]. In many cases, people with schizophrenia are not adequately screened and treated for diabetes, dyslipidemia, and high blood pressure [28]. The lack of seeking medical care, even during acute cardiovascular syndromes, represents another significant obstacle [29]. Finally, when patients with severe mental illness develop cardiovascular disease, they experience earlier mortality than patients without mental illness. Indeed, a population-based cohort study of 4.6 million people in Denmark showed that 8.26% of people with severe mental illness died 5 years after their first contact with the healthcare system for heart disease, compared with 2.86% for patients without severe mental illness [29].

Even though neither of our patients had cancer, it seems necessary to remind that cancer is described as a cause of mortality in several studies, perhaps due to the high age of the sample. Thus, the study by CL Charrel showed 12.7% of patients who died from cancer and had an average age at death of 54 years [15]. Another study conducted by Catherine Ha found that 18% of deaths were accountable to cancer and had a mean age at death of 75 years [30]. Screening and diagnostic efforts may also have an impact on these outcomes.

Other studies have shown that infections account for a significant percentage of deaths [24, 31]. This can be explained by self-neglect, apathy, cognitive impairment, drug and alcohol problems, lack of hygiene, homelessness, and poverty, which leads to malnutrition and vitamin deficiencies and increases the risk of infection.

Another factor contributing to the higher mortality rates in this patient group is the intake of some antipsychotic and antidepressant medications which have metabolic side effects [32,33,34,35].

Psychiatrists frequently focus on the mental rather than physical health of their patients, rarely undertake physical examinations, and often have poor communication and collaboration with primary care physicians or other clinicians, partly due to the long-standing separation of psychiatric departments from other medical wards or hospitals [36,37,38]. Conversely, non-psychiatric clinicians frequently have a negative attitude towards people with mental disorders, underestimating the seriousness of their complaints of signs of physical illness.

Conclusion

Mortality is an indicator of health system performance. Thus, the analysis of the causes of death and the risk factors associated with death would make it possible to target primary and secondary prevention and reduce adverse events that could have been avoided by applying prevention measures.

The WHO (World Health Organization) has recently developed international guidelines on how to improve physical health in people with severe mental disorders [39]. According to the WHO, premature mortality is a complex phenomenon resulting from the interaction of several risk factors; therefore, a multilevel approach is needed, in which the different stakeholders involved in health care provision establishes a plan for the long-term management of physical and mental health conditions [40, 41]. The results of this study indicate the need to remove barriers to the integration of medical and mental health care for patients with severe mental illness to reduce excess mortality, which is our long waiting hope, and the beginning of the path.

Limitations

This study was based on the medical files of patients, so it has some lacking information, and it was not possible to contact their families.

Most causes of death were recorded based on the clinic alone, and no further investigations were done. The autopsy was not always performed.

Other studies may be, if conducted prospectively, better at identifying the causes and risk factors of mortality in this vulnerable and specific population.

Availability of data and materials

The datasets used and/or analyzed during the current study are available from the corresponding author on reasonable request.

Abbreviations

NCDs:

Non-communicable diseases

Sd:

Standard deviation

COPD:

Chronic obstructive pulmonary disease

WHO:

World Health Organization

References

  1. Whiteford HA, Degenhardt L, Rehm J, Baxter AJ, Ferrari AJ, Erskine HE et al (2013) Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010. Lancet 382(9904):1575–1586

    Article  PubMed  Google Scholar 

  2. Laursen TM (2011) Life expectancy among persons with schizophrenia or bipolar affective disorder. Schizophr Res 131(1–3):101–104

    Article  PubMed  Google Scholar 

  3. Nordentoft M, Wahlbeck K, Hällgren J, Westman J, Ösby U, Alinaghizadeh H et al (2013) Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS ONE 8(1):e55176

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Ali S, Santomauro D, Ferrari AJ, Charlson F (2022) Excess mortality in severe mental disorders: a systematic review and meta-regression. J Psychiatr Res 1(149):97–105

    Article  Google Scholar 

  5. World Health Organization (2018) World health statistics 2018: monitoring health for the SDGs, sustainable development goals [Internet]. Geneva: World Health Organization. [cited 2023 Jan 1]. Available from: https://apps.who.int/iris/handle/10665/272596

  6. Hoang U, Goldacre MJ, Stewart R (2013) Avoidable mortality in people with schizophrenia or bipolar disorder in England. Acta Psychiatr Scand 127(3):195–201

    Article  CAS  PubMed  Google Scholar 

  7. Elyamani R, Soulaymani A, Hami H (2021) Epidemiology of cardiovascular diseases in Morocco: a systematic review. Rev Diabet Stud RDS 17(2):57–67

    Article  PubMed  Google Scholar 

  8. Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al (2016) Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet 387(10028):1672–85

  9. Wainberg ML, Scorza P, Shultz JM, Helpman L, Mootz JJ, Johnson KA et al (2017) Challenges and opportunities in global mental health: a research-to-practice perspective. Curr Psychiatry Rep 19(5):28

    Article  PubMed  PubMed Central  Google Scholar 

  10. Garcia-Portilla MP, Saiz PA, Bascaran MT, Martínez AS, Benabarre A, Sierra P et al (2009) Cardiovascular risk in patients with bipolar disorder. J Affect Disord 115(3):302–308

    Article  PubMed  Google Scholar 

  11. Druss B, Walker E (2011) Mental disorders and medical comorbidity. Synth Proj Res Synth Rep 1:1–26

    Google Scholar 

  12. Khamker N, Moola NM, Roos JL, Rheeder P (2010) Profile of mortality of patients admitted to Weskoppies Psychiatric Hospital in South Africa over a 5-year period (2001–2005). Afr J Psychiatry (Johannesbg) 13(3):211–217 (PMID: 20957320)

    CAS  PubMed  Google Scholar 

  13. Zgueb Y, Jomli R, Ouertani A, Hechmi S, Ouanes S, Nacef F et al (2014) La mortalité à l’hôpital psychiatrique de Tunis : étude rétrospective sur 11ans. L’Encéphale 40(5):416–422

    Article  CAS  PubMed  Google Scholar 

  14. Shinde SS, Nagarajaiah, Narayanaswamy JC, Viswanath B, Kumar NC, Gangadhar BN, et al (2014) Mortality among inpatients of a psychiatric hospital: Indian perspective. Indian J Psychol Med 36(2):142–6

  15. Charrel CL, Plancke L, Genin M, Defromont L, Ducrocq F, Vaiva G et al (2015) Mortality of people suffering from mental illness: a study of a cohort of patients hospitalised in psychiatry in the North of France. Soc Psychiatry Psychiatr Epidemiol 50(2):269–277

    Article  PubMed  Google Scholar 

  16. Ali DH, Shorab E, Hassan GAM, elRasheed AH, Soltan MAR, Elrassas H (2021) Long-term observations on the mortality of mentally ill patients admitted to a short-stay psychiatric hospital: 23 years retrospective Egyptian study. Middle East Curr Psychiatry 28(1):80

    Article  Google Scholar 

  17. Brown S, Inskip H, Barraclough B (2000) Causes of the excess mortality of schizophrenia. Br J Psychiatry J Ment Sci 177:212–217

    Article  CAS  Google Scholar 

  18. Fulga I, Neagu AI, Neagu M, Fulga A (2021) Mortality among involuntary inpatients of psychiatric hospital. Egypt J Forensic Sci 11(1):13

    Article  Google Scholar 

  19. Le BF (2018) risque cardiovasculaire du diabétique : les évidences. Bull Académie Natl Médecine 202(5–6):887–895

    Google Scholar 

  20. Roberts E, Jones L, Blackman A, Dewhurst T, Matcham F, Kan C et al (2017) The prevalence of diabetes mellitus and abnormal glucose metabolism in the inpatient psychiatric setting: a systematic review and meta-analysis. Gen Hosp Psychiatry 45:76–84

    Article  PubMed  Google Scholar 

  21. Belghazi D, Moussaoui D, Kadri N (2016) Spécificités épidémiologiques, cliniques et culturelles des patients hospitalisés au centre psychiatrique universitaire Ibn-Rochd de Casablanca. Ann Méd-Psychol Rev Psychiatr 174(2):100–104

    Google Scholar 

  22. Swaraj S, Wang M, Chung D, Curtis J, Firth J, Ramanuj PP et al (2019) Meta-analysis of natural, unnatural and cause-specific mortality rates following discharge from in-patient psychiatric facilities. Acta Psychiatr Scand 140(3):244–264

    Article  CAS  PubMed  Google Scholar 

  23. Malomo IO, Aina OF, Ladapo HT, Owoeye AO (2003) Ten-year mortality review in a pioneer psychiatric hospital in West Africa. East Afr Med J 80(7):379–383. https://doi.org/10.4314/eamj.v80i7.8723. (PMID: 16167755)

    Article  CAS  PubMed  Google Scholar 

  24. Osman AH, Abdalhai KA, Hassan I, Elmubark MA, Elawad LA (2020) Mortality characteristics in Sudan in national psychiatric hospitals: 5-year review of hospital mortality. Middle East Curr Psychiatry 27(1):44

    Article  Google Scholar 

  25. Walker ER, McGee RE, Druss BG (2015) Mortality in mental disorders and global disease burden implications: a systematic review and meta-analysis. JAMA Psychiat 72(4):334–341

    Article  Google Scholar 

  26. Lawrence D, Hancock KJ, Kisely S (2013) The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ 346(may21 1):f2539–f2539

  27. Laursen TM, Munk-Olsen T, Agerbo E, Gasse C, Mortensen PB (2009) Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. Arch Gen Psychiatry 66(7):713–720

    Article  PubMed  Google Scholar 

  28. Nasrallah HA, Meyer JM, Goff DC, McEvoy JP, Davis SM, Stroup TS et al (2006) Low rates of treatment for hypertension, dyslipidemia and diabetes in schizophrenia: data from the CATIE schizophrenia trial sample at baseline. Schizophr Res 86(1):15–22

    Article  PubMed  Google Scholar 

  29. Hennekens CH, Hennekens AR, Hollar D, Casey DE (2005) Schizophrenia and increased risks of cardiovascular disease. Am Heart J 150(6):1115–1121

    Article  PubMed  Google Scholar 

  30. Ha C, Decool E, Chan Chee C (2017) Mortalité des personnes souffrant de troubles mentaux. Analyse en causes multiples des certificats de décès en France, 2000–2013. Bull Epidémiol Hebd (23):500–8. http://invs.santepubliquefrance.fr/beh/2017/23/2017_23_2.htm. Accessed 27 Mar 2023

  31. Abiodun OA (1988) Mortality in a psychiatric population: a Nigerian psychiatric hospital experience. Acta Psychiatr Scand 77(6):654–657

    Article  CAS  PubMed  Google Scholar 

  32. Taipale H, Tanskanen A, Mehtälä J, Vattulainen P, Correll CU, Tiihonen J (2020) 20-year follow-up study of physical morbidity and mortality in relationship to antipsychotic treatment in a nationwide cohort of 62,250 patients with schizophrenia (FIN20). World Psychiatry 19(1):61–68

    Article  PubMed  PubMed Central  Google Scholar 

  33. Wen FK, Crosby K, Miller BH, Rommen M, Kirzner SJ, Hoberecht T et al (2020) Association of first-line antidepressants and incident adverse metabolic effects. Can Fam Physician 66(12):898–900

    Article  PubMed  PubMed Central  Google Scholar 

  34. Correll CU, Sikich L, Reeves G, Johnson J, Keeton C, Spanos M, et al (2020) Metformin add-on vs. antipsychotic switch vs. continued antipsychotic treatment plus healthy lifestyle education in overweight or obese youth with severe mental illness: results from the IMPACT trial. World Psychiatry 19(1):69–80

  35. Kishimoto T, Hagi K, Nitta M, Kane JM, Correll CU (2019) Long-term effectiveness of oral second-generation antipsychotics in patients with schizophrenia and related disorders: a systematic review and meta-analysis of direct head-to-head comparisons. World Psychiatry 18(2):208–224

    Article  PubMed  PubMed Central  Google Scholar 

  36. Chew-Graham CA, Gilbody S, Curtis J, Holt RI, Taylor AK, Shiers D (2021) Still ‘being bothered about Billy’: managing the physical health of people with severe mental illness. Br J Gen Pract 71(709):373–376

    Article  PubMed  PubMed Central  Google Scholar 

  37. Lerbæk B, Jørgensen R, Aagaard J, Nordgaard J, Buus N (2019) Mental health care professionals’ accounts of actions and responsibilities related to managing physical health among people with severe mental illness. Arch Psychiatr Nurs 33(2):174–181

    Article  PubMed  Google Scholar 

  38. McBain H, Lamontagne-Godwin F, Haddad M, Simpson A, Chapman J, Jones J et al (2018) Management of type 2 diabetes mellitus in people with severe mental illness: an online cross-sectional survey of healthcare professionals. BMJ Open 8(2):e019400

    Article  PubMed  PubMed Central  Google Scholar 

  39. McEwen BS (2020) The untapped power of allostasis promoted by healthy lifestyles. World Psychiatry 19(1):57–58

    Article  PubMed  PubMed Central  Google Scholar 

  40. Groeneweg B (2019) The all-encompassing perspective of the mental health care patient. World Psychiatry 18(3):296–297

    Article  PubMed  PubMed Central  Google Scholar 

  41. Galderisi S, De Hert M, Del Prato S, Fagiolini A, Gorwood P, Leucht S et al (2021) Identification and management of cardiometabolic risk in subjects with schizophrenia spectrum disorders: a Delphi expert consensus study. Eur Psychiatry 64(1):e7

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

None.

Author information

Authors and Affiliations

Authors

Contributions

CK: Data collection, bibliographic research, and writing. NA: Data collection, bibliographic research, and writing. HC: Data collection, bibliographic research, and writing. KMA: Design of the study, supervision, and monitoring of the study. The authors read and approved the final manuscript.

Corresponding author

Correspondence to Chouaib Khlil.

Ethics declarations

Ethics approval and consent to participate

The right to direct access to data from the medical records of patients who were hospitalized between January 2011 and January 2021 was granted to us after a request to the head of the Psychiatry Department at the University Hospital of Casablanca, respecting the rules of professional secrecy and anonymity.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Khlil, C., Attouche, N., Choujaa, H. et al. Mortality in a Moroccan psychiatric hospital. Middle East Curr Psychiatry 30, 60 (2023). https://doi.org/10.1186/s43045-023-00333-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s43045-023-00333-1

Keywords